Bionomics (BNOX) Stock Forecast, Price Target & Predictions
BNOX Stock Forecast
Bionomics stock forecast is as follows: an average price target of $6.00 (represents a 2059.05% upside from BNOX’s last price of $0.28) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.
BNOX Price Target
BNOX Analyst Ratings
Buy
Bionomics Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Dec 19, 2022 | Joshua Schimmer | Evercore ISI | $6.00 | $5.89 | 1.87% | 2059.05% |
10
Bionomics Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | - |
Avg Price Target | - | - | - |
Last Closing Price | $0.28 | $0.28 | $0.28 |
Upside/Downside | -100.00% | -100.00% | -100.00% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Jun 13, 2024 | H.C. Wainwright | Buy | Buy | Hold |
Mar 10, 2023 | Evercore ISI | - | Outperform | Upgrade |
Dec 19, 2022 | William Blair | Outperform | Outperform | Hold |
10
Bionomics Financial Forecast
Bionomics Revenue Forecast
Quarter
Sep 24 | Jun 24 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | - | - | - | - | $65.91K |
Avg Forecast | - | $2.64M | $-524.11K | $2.56M | $5.07M |
High Forecast | - | $2.64M | $-524.11K | $2.56M | $5.07M |
Low Forecast | - | $2.64M | $-524.11K | $2.56M | $5.07M |
# Analysts | - | 1 | - | 1 | 1 |
Surprise % | - | - | - | - | 0.01% |
Forecast
Bionomics EBITDA Forecast
Quarter
Sep 24 | Jun 24 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
# Analysts | - | 1 | - | 1 | 1 |
EBITDA | - | - | - | - | $-5.48M |
Avg Forecast | - | $-528.72K | $104.82K | $-512.00K | $-1.01M |
High Forecast | - | $-528.68K | $104.82K | $-512.00K | $-1.01M |
Low Forecast | - | $-528.75K | $104.82K | $-512.00K | $-1.01M |
Surprise % | - | - | - | - | 5.41% |
Forecast
Bionomics Net Income Forecast
Quarter
Sep 24 | Jun 24 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
# Analysts | - | 1 | - | 1 | 1 |
Net Income | - | - | - | - | $-5.44M |
Avg Forecast | $63.75M | $-39.87M | $-54.06M | $-30.52M | $80.41M |
High Forecast | $63.75M | $-39.87M | $-54.06M | $-30.52M | $80.41M |
Low Forecast | $63.75M | $-39.87M | $-54.06M | $-30.52M | $80.41M |
Surprise % | - | - | - | - | -0.07% |
Forecast
Bionomics SG&A Forecast
Quarter
Sep 24 | Jun 24 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
# Analysts | - | 1 | - | 1 | 1 |
SG&A | - | - | - | - | $2.85M |
Avg Forecast | - | $302.14M | $-59.90M | $292.59M | $579.01M |
High Forecast | - | $302.16M | $-59.90M | $292.59M | $579.01M |
Low Forecast | - | $302.12M | $-59.90M | $292.59M | $579.01M |
Surprise % | - | - | - | - | 0.00% |
Forecast
Bionomics EPS Forecast
Quarter
Sep 24 | Jun 24 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
# Analysts | - | 1 | - | 1 | 1 |
EPS | - | - | - | - | $-0.72 |
Avg Forecast | $2.27 | $-1.42 | $-1.93 | $-1.09 | $2.86 |
High Forecast | $2.27 | $-1.42 | $-1.93 | $-1.09 | $2.86 |
Low Forecast | $2.27 | $-1.42 | $-1.93 | $-1.09 | $2.86 |
Surprise % | - | - | - | - | -0.25% |
Forecast
Bionomics Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
BNOX | Bionomics | $0.28 | $6.00 | 2042.86% | Buy |
PMVP | PMV Pharmaceuticals | $1.61 | $18.00 | 1018.01% | Buy |
ANTX | AN2 Therapeutics | $1.23 | $8.75 | 611.38% | Buy |
AVTE | Aerovate Therapeutics | $2.61 | $13.00 | 398.08% | Hold |
ANEB | Anebulo Pharmaceuticals | $1.50 | $6.00 | 300.00% | Buy |
ACRV | Acrivon Therapeutics | $6.44 | $21.83 | 238.98% | Buy |
RZLT | Rezolute | $4.86 | $13.50 | 177.78% | Buy |
ADAG | Adagene | $2.26 | $5.00 | 121.24% | Buy |